The effort involves several agencies that typically have little to do with wind power, including the Health and Human Services Department. By Maxine Joselow Lisa Friedman and Brad Plumer Reporting ...
Data establish maximum tolerated dose, supporting progression of lead neuroplastogen compound EB-003 toward IND-enabling studies and First-in-Human clinical trials CAMBRIDGE, Mass., August 28, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback